Key result
M-band TTN truncating variants are linked to higher risk of sudden cardiac death.
Why the study?
Titin truncating variants show incomplete penetrance and phenotypic variability, and emerging molecular evidence suggests variant location may influence disease mechanisms, prompting investigation into its effect on clinical phenotype and prognosis.
Does the location of TTN truncating variants affect clinical phenotype and prognosis in patients with non-hypertrophic cardiomyopathy?
Cohort (n=467)
Yes
Does the location of TTN truncating variants affect clinical phenotype and prognosis in patients with non-hypertrophic cardiomyopathy?
The location of titin truncating variants significantly influences the risk of sudden cardiac death and major ventricular arrhythmias, with M-band variants conferring the highest risk, suggesting the need for variant site-specific risk stratification.
Answers are grounded in this paper and cite their sources.
M-band TTN variants may support arrhythmia-focused risk stratification in DCM; extends genotype-phenotype data but remains hypothesis-generating pending prospective validation.
BACKGROUND: Titin truncating variants ( TTN tv) represent the most common genotype underlying dilated cardiomyopathy but are also detected in the general population, exhibiting incomplete penetrance and marked phenotypic variability. This heterogeneity complicates clinical interpretation and risk stratification. Emerging molecular evidence suggests that truncating location within the gene may influence disease mechanisms. We aimed to investigate whether TTNt v location also affects clinical phenotype and prognosis. METHODS: We established an international multicenter registry of phenotypically affected carriers of pathogenic or likely pathogenic TTN tv. Patients were classified into 3 groups: A-band, Z/I-band, and M-band. A case-control study assessed the enrichment of TTN tv across regions. The primary outcome was a composite of all-cause mortality and heart transplantation. Secondary outcomes included: (1) sudden cardiac death or major ventricular arrhythmias and (2) heart failure-related death/heart transplantation/left ventricular assist device implantation. RESULTS: The study included 467 patients (81% probands, 73% male, median age 47 years, 81% dilated cardiomyopathy phenotype). Most carried TTN tv in the A-band (80% versus 15% Z/I-band and 5% M-band). All groups showed enrichment compared with GnomAD, with greater Bayesian-estimated penetrance for A-band variants. Over a median follow-up of 83 months, the primary end point was similar across groups. However, the risk of sudden cardiac death/major ventricular arrhythmias was significantly higher in M-band carriers (45% M-band versus 23% Z/I-band versus 12% A-band; P =0.001), especially as the first disease manifestation. Band location independently predicted sudden cardiac death/major ventricular arrhythmias risk, whereas left ventricular ejection fraction was predictive only in A- and Z/I-band groups. CONCLUSIONS: TTN tv are differently enriched across the gene in patients with dilated cardiomyopathy/nondilated left ventricular cardiomyopathy. Penetrance and risk of sudden cardiac death/major ventricular arrhythmias differ according to variant location, supporting the TTN truncation site as a parameter that should be considered for personalized risk stratification in TTN cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Perotto et al. (2026) conducted a cohort in Titin-Induced Cardiomyopathy (n=467). M-band TTN truncating variants vs. A-band and Z/I-band TTN truncating variants was evaluated on Composite of all-cause mortality and heart transplantation. While the primary endpoint of all-cause mortality and heart transplantation was similar across groups, M-band TTN truncating variants were associated with a significantly higher risk of sudden cardiac death or major ventricular arrhythmias compared to Z/I-band and A-band variants.
Synapse has enriched 10 related papers. Consider them for comparative context: